Crucell N.V. - Strategy and SWOT Report
Datamonitor, October 2011, Pages: 50
Crucell N.V. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.
Features:
- Detailed information on Crucell N.V. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Crucell N.V. in the form of a SWOT analysis
- An in-depth view of the business model of Crucell N.V. including a breakdown and examination of key business segments
- Intelligence on Crucell N.V.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Crucell N.V., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Crucell is a biopharmaceutical company engaged in discovering, developing and commercializing vaccines and antibodies for the treatment of infectious diseases. The company's product portfolio is focused on three distinct areas: pediatric, travel and endemic, and respiratory. The company primarily operates in Europe, North America and Asia. It is headquartered in Leiden, the Netherlands and employed 1,400 people as of December 31, 2010. Johnson & Johnson completed the acquisition of Crucell for $2.3 billion in March 2011. The company recorded revenues of E365.4 million ($484.8 million-) during the financial year (FY) ended December 2010, an increase of 2.1% over FY2009. The operating loss of the company was E34.3 million ($45.5 million-) during FY2010, as compared with an operating profit of E39 million ($51.7 million-) in FY2009. The net loss was E27.6 million ($36.6 million-) in FY2010, as compared with a net profit of E23.9 million ($31.7 million-) in FY2009. - Calculated using the constant conversion rate of E1 = $1.3267 for the financial year ended December 31, 2010.
Reasons to Purchase:
- Gain understanding of Crucell N.V. and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Crucell N.V. as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Crucell N.V.’s business structure, strategy and prospects
Company Snapshot
Crucell N.V.: Company Overview
Crucell N.V.: Overview and Key Facts
Crucell N.V.: Overview
Crucell N.V.: Key Facts
Crucell N.V.: Key Employees
Crucell N.V.: Key Employee Biographies
Crucell N.V.: Major Products and Services
Crucell N.V.: Company History
Crucell N.V.: Management Statement
Crucell N.V.: Locations and Subsidiaries
Crucell N.V.: Key Competitors
Crucell N.V.: Company Analysis
Crucell N.V.: Business Description
Crucell N.V.: SWOT Analysis
Crucell N.V.: SWOT Overview
Crucell N.V.: Strengths
Crucell N.V.: Weaknesses
Crucell N.V.: Opportunities
Crucell N.V.: Threats
Crucell N.V.: Corporate Financial Deals Activity
Crucell N.V.: Financial Deals Overview
Crucell N.V.: Targets and Partners
Crucell N.V.: Top Deals 2007 -YTD-
Crucell N.V.: Advisors
Crucell N.V.: Top Legal Advisors
Crucell N.V.: Top Financial Advisors
Crucell N.V.: Mergers and Acquisitions
Crucell N.V.: Capital Raising
Crucell N.V.: Partnership
Crucell N.V.: Divestments
Crucell N.V.: Private Equity and Ownership
Crucell N.V.: Recent Developments
Crucell N.V.: News and Events Summary
Crucell N.V.: Business Expansion
Crucell N.V.: Financial Deals
Crucell N.V.: Research & Development
Appendix
Contact Us
Methodology
Definitions
About Datamonitor
List of Tables
Table 1: Crucell N.V.: Key Facts
Table 2: Crucell N.V.: Key Employees
Table 4: Crucell N.V.: Key Competitors
Table 5: Crucell N.V.: Deal Activity by Deal Type - Volume (TTM)
Table 6: Crucell N.V.: Deal Activity by Deal Type - Volume (2007 - YTD-2011)
Table 7: Crucell N.V.: Targets and Partners
Table 8: Crucell N.V.: Top Deals 2007 -YTD-
Table 9: Crucell N.V.: Legal Advisor Ranking by Value (US$m)
Table 10: Crucell N.V.: Financial Advisor Ranking by Value (US$m)
Table 11: Crucell N.V.: M&A Volume and Value Trend (2007 - YTD-2011)
Table 12: Crucell N.V.: M&A Activity by Geography (2007 - YTD-2011)
Table 13: Crucell N.V.: Capital Raising Volume and Value Trend (2007 - YTD-2011)
Table 14: Crucell N.V.: Capital Raising by Deal Type (2007 - YTD-2011)
Table 15: Crucell N.V.: Partnership Volume and Value Trend (2007 - YTD-2011)
Table 16: Crucell N.V.: Partnership Trend by Deal Type (2007 - YTD-2011)
Table 17: Crucell N.V.: Divestments Volume and Value Trend (2007 - YTD-2011)
Table 18: Crucell N.V.: Divestments by Geography (2007 - YTD-2011)
Table 19: Crucell N.V.: Private Equity and Ownership Volume and Value Trend (2007 - YTD-2011)
Table 20: Crucell N.V.: Private Equity and Ownership Volume by Deal Type (2007 - YTD-2011)
Table 21: Crucell N.V.: News and Events Summary
Table 22: Crucell N.V.: Business Expansion
Table 23: Crucell N.V.: Financial Deals
Table 24: Crucell N.V.: Research & Development
List of Figures
Figure 1: Crucell N.V.: Deal Activity by Deal Type - Volume (TTM)
Figure 2: Crucell N.V.: Deal Activity by Deal Type - Volume (2007 - YTD-2011)
Figure 3: Crucell N.V.: M&A Volume and Value Trend (2007 - YTD-2011)
Figure 4: Crucell N.V.: M&A Activity by Geography (2007 - YTD-2011)
Figure 5: Crucell N.V.: Capital Raising Volume and Value Trend (2007 - YTD-2011)
Figure 6: Crucell N.V.: Capital Raising by Deal Type (2007 - YTD-2011)
Figure 7: Crucell N.V.: Partnership Volume and Value Trend (2007 - YTD-2011)
Figure 8: Crucell N.V.: Partnership Trend by Deal Type (2007 - YTD-2011)
Figure 9: Crucell N.V.: Divestments Volume and Value Trend (2007 - YTD-2011)
Figure 10: Crucell N.V.: Divestments by Geography (2007 - YTD-2011)
Figure 11: Crucell N.V.: Private Equity and Ownership Volume and Value Trend (2007 - YTD-2011)
Figure 12: Crucell N.V.: Private Equity and Ownership Volume by Deal Type (2007 - YTD-2011)
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
